1887

Abstract

CD46 (or membrane cofactor protein) protects autologous cells from complement-mediated lysis and has been expressed as a transgene in pigs to overcome complement-mediated hyperacute rejection of porcine organs upon transplantation into primates. Since CD46 has been identified as a receptor for measles virus (MV), the susceptibility of CD46-transgenic (tg) pig peripheral blood mononuclear cells (PBMC) to infection with MV strains which do and do not use CD46 as receptor was investigated. Surprisingly, it was found that MV vaccine strains (e.g. Edmonston) bound to tg as well as non-tg pig PBMC. Phytohaemagglutinin-stimulated CD46-tg and non-tg pig PBMC were equally well infected with MV vaccine strains irrespective of CD46 expression. Upon infection, tg CD46 was downregulated from the cell surface. In contrast, the binding capacity for MV wild-type strains to pig and human PBMC was low, irrespective of CD46 expression. These MV strains did not infect tg or non-tg pig cells. Expression of endogenous pig CD46 was detected with polyclonal sera against human CD46. After infection of pig PBMC with MV strain Edmonston, endogenous pig CD46 was also downregulated. This suggests an interaction between MV Edmonston and pig CD46. However, polyclonal CD46 sera did not inhibit infection with MV Edmonston indicating that CD46 may not exclusively act as a receptor for MV on these cells. Interestingly, similar results were observed using human PBMC. Data suggest that CD46 downregulation after interaction with MV may also occur in porcine organs which express endogenous and/or human CD46 as a means of protection against complement-mediated damage.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-6-1431
2000-06-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/6/0811431a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-6-1431&mimeType=html&fmt=ahah

References

  1. Atkinson, J. P., Krych, M., Nickells, M., Birmingham, D., Subramanian, V. B., Clemenza, L., Alvarez, K. & Liszewski, K. ( 1994; ). Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms. Clinical and Experimental Immunology 97, 2-3.
    [Google Scholar]
  2. Bartz, R., Brinckmann, U., Dunster, L., Rima, B., ter Meulen, V. & Schneider-Schaulies, J. ( 1996; ). Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 334–337.
    [Google Scholar]
  3. Bartz, R., Firsching, R., Rima, B., ter Meulen, V. & Schneider-Schaulies, J. ( 1998; ). Differential receptor usage by measles virus strains. Journal of General Virology 79, 1015-1025.
    [Google Scholar]
  4. Bergelson, J. M., Chan, M., Solomon, K. R., St-John, N. F. & Finberg, R. W. ( 1994; ). Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proceedings of the National Academy of Sciences, USA 91, 6245-6249.[CrossRef]
    [Google Scholar]
  5. Bergelson, J. M., Mohanty, J. G., Crowell, R. L., St-John, N. F., Lublin, D. M. & Finberg, R. W. ( 1995; ). Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology 69, 1903-1906.
    [Google Scholar]
  6. Blixenkrone-Moller, M., Bernard, A., Bencsik, A., Sixt, N., Diamond, L. E., Logan, J. S. & Wild, F. ( 1998; ). Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249, 238-248.[CrossRef]
    [Google Scholar]
  7. Buchholz, C. J., Schneider, U., Devaux, P., Gerlier, D. & Cattaneo, R. ( 1996; ). Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. Journal of Virology 70, 3716-3723.
    [Google Scholar]
  8. Buchholz, C. J., Koller, D., Devaux, P., Mummenthaler, C., Schneider-Schaulies, J., Braun, W., Gerlier, D. & Cattaneo, R. ( 1997; ). Mapping of the primary binding site of measles virus to its receptor CD46. Journal of Biological Chemistry 272, 22072-22079.[CrossRef]
    [Google Scholar]
  9. Byrne, G. W., McCurry, K. R., Martin, M. J., McClellan, S. M., Platt, J. L. & Logan, J. S. ( 1997; ). Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63, 149-155.[CrossRef]
    [Google Scholar]
  10. Carrington, C. A., Richards, A. C., Cozzi, E., Langford, G., Yannoutsos, N. & White, D. J. ( 1995; ). Expression of human DAF and MCP on pig endothelial cells protects from human complement. Transplantation Proceedings 27, 321-323.
    [Google Scholar]
  11. Diamond, L. E., Martin, M. J., Adams, D., Naficy, S., O’Hair, D. P. O., Lawson, J. H., Platt, J. L. & Logan, J. S. (1997). Transgenic pig hearts and kidneys expressing human CD59, CD55, or CD46 are protected from hyperacute rejection upon transplantation into baboons. In The 4th International Congress for Xenotransplantation, Nantes, France. Abstract O185.
  12. Dörig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. ( 1993; ). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.[CrossRef]
    [Google Scholar]
  13. Firsching, R., Buchholz, C. J., Schneider, U., Cattaneo, R., ter Meulen, V. & Schneider-Schaulies, J. ( 1999; ). Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. Journal of Virology 73, 5265-5273.
    [Google Scholar]
  14. Galbraith, S. E., Tiwari, A., Baron, M. D., Lund, B. T., Barrett, T. & Cosby, S. L. ( 1998; ). Morbillivirus downregulation of CD46. Journal of Virology 72, 10292-10297.
    [Google Scholar]
  15. Gerlier, D., Loveland, B., Varior-Krishnan, G., Thorley, B., McKenzie, I. F. C. & Rabourdin-Combe, C. ( 1994; ). Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails. Journal of General Virology 75, 2163-2171.[CrossRef]
    [Google Scholar]
  16. Horvat, B., Rivailler, P., Varior-Krishnan, G., Cardoso, A., Gerlier, D. & Rabourdin-Combe, C. ( 1996; ). Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infection. Journal of Virology 70, 6673-6681.
    [Google Scholar]
  17. Hsu, E. C., Dörig, R., Sarangi, F., Marcil, A., Iorio, C. & Richardson, C. D. ( 1997; ). Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. Journal of Virology 71, 6144-6154.
    [Google Scholar]
  18. Hsu, E. C., Sarangi, F., Iorio, C., Sidhu, M. S., Udem, S. A., Dillehay, D. L., Xu, W., Rota, P., Bellini, W. J. & Richardson, C. D. ( 1998; ). A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. Journal of Virology 72, 2905-2916.
    [Google Scholar]
  19. Johnstone, R. W., Russel, S. M., Loveland, B. E. & McKenzie, I. F. C. ( 1993; ). Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Molecular Immunology 30, 1231-1241.[CrossRef]
    [Google Scholar]
  20. Kallstrom, H., Liszewski, M., Atkinson, J. P. & Jonsson, A. B. ( 1997; ). Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Molecular Microbiology 25, 639-647.[CrossRef]
    [Google Scholar]
  21. Krantic, S., Gimenez, C. & Rabourdin-Combe, C. ( 1995; ). Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. Journal of General Virology 76, 2793-2800.[CrossRef]
    [Google Scholar]
  22. Lecouturier, V., Fayolle, J., Caballero, M., Carabana, J., Celma, M. L., Fernandez-Munoz, R., Wild, T. F. & Buckland, R. ( 1996; ). Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. Journal of Virology 70, 4200-4204.
    [Google Scholar]
  23. Liszewski, M. K., Post, T. W. & Atkinson, J. P. ( 1991; ). Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annual Review of Immunology 9, 431-455.[CrossRef]
    [Google Scholar]
  24. Logan, J. S. & Martin, M. J. ( 1994; ). Transgenic swine as a recombinant production system for human hemoglobin. Methods in Enzymology 231, 435.
    [Google Scholar]
  25. Loveland, B. E., Johnstone, R. W., Russell, S. M., Thorley, B. R. & McKenzie, I. F. C. ( 1993; ). Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. Transplantation and Clinical Immunology 1, 101-108.[CrossRef]
    [Google Scholar]
  26. McCurry, K. R., Kooyman, D. L., Alvarado, C. G., Cotterell, A. H., Martin, M. J., Logan, J. S. & Platt, J. L. ( 1995; ). Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1, 423-427.[CrossRef]
    [Google Scholar]
  27. Maisner, A., Schneider-Schaulies, J., Liszewski, M. K., Atkinson, J. P. & Herrler, G. ( 1994; ). Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor determinant. Journal of Virology 68, 6299-6304.
    [Google Scholar]
  28. Manchester, M., Liszewski, M. K., Atkinson, J. P. & Oldstone, M. B. A. ( 1994; ). Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proceedings of the National Academy of Sciences, USA 91, 2161-2165.[CrossRef]
    [Google Scholar]
  29. Manchester, M., Valsamakis, A., Kaufman, R., Liszewski, M. K., Alvarez, J., Atkinson, J. P., Lublin, D. M. & Oldstone, M. B. A. ( 1995; ). Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proceedings of the National Academy of Sciences, USA 92, 2303-2307.[CrossRef]
    [Google Scholar]
  30. Manchester, M., Gairin, J. E., Patterson, J. B., Alvarez, J., Liszewski, M. K., Eto, D. S., Atkinson, J. P. & Oldstone, M. B. A. ( 1997; ). Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1–2. Virology 233, 174-184.[CrossRef]
    [Google Scholar]
  31. Menezes, J., Leibold, W., Klein, G. & Clements, G. ( 1975; ). Establishment and characterization of an Epstein–Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt’s lymphoma. Biomedicine 22, 276-284.
    [Google Scholar]
  32. Mrkic, B., Pavlovic, J., Rülicke, T., Volpe, P., Buchholz, C. J., Hourcade, D., Atkinson, J. P., Aguzzi, A. & Cattaneo, R. ( 1998; ). Measles virus spread and pathogenesis in genetically modified mice. Journal of Virology 72, 7420-7427.
    [Google Scholar]
  33. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. ( 1993a; ). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. Journal of Virology 67, 6025-6032.
    [Google Scholar]
  34. Naniche, D., Wild, T. F., Rabourdin-Combe, C. & Gerlier, D. ( 1993b; ). Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. Journal of General Virology 74, 1073-1079.[CrossRef]
    [Google Scholar]
  35. Niewiesk, S., Schneider-Schaulies, J., Ohnimus, H., Jassoy, C., Schneider-Schaulies, S., Diamond, L., Logan, J. S. & ter Meulen, V. ( 1997; ). CD46 expression does not overcome intracellular block of measles virus in transgenic rats. Journal of Virology 71, 7969-7973.
    [Google Scholar]
  36. Nowicki, B., Hart, A., Coyne, K. E., Lublin, D. M. & Nowicki, S. ( 1993; ). Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell–cell interaction. Journal of Experimental Medicine 178, 2115-2121.[CrossRef]
    [Google Scholar]
  37. Okada, N., Liszewski, M. K., Atkinson, J. P. & Capron, M. ( 1995; ). Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proceedings of the National Academy of Sciences, USA 92, 2489-2493.[CrossRef]
    [Google Scholar]
  38. Oldstone, M. B. A., Lewicki, H., Thomas, D., Tishon, A., Dales, S., Patterson, J., Manchester, M., Homann, D., Naniche, D. & Holz, A. ( 1999; ). Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98, 629-640.[CrossRef]
    [Google Scholar]
  39. Patience, C., Takeuchi, Y. & Weiss, R. A. ( 1997; ). Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine 3, 282-286.[CrossRef]
    [Google Scholar]
  40. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S. & Berger, E. A. ( 1999; ). CD46 is a cellular receptor for human herpesvirus 6. Cell 99, 817-827.[CrossRef]
    [Google Scholar]
  41. Schneider-Schaulies, J., Schnorr, J.-J., Brinckmann, U., Dunster, L. M., Baczko, K., Liebert, U. G., Schneider-Schaulies, S. & ter Meulen, V. ( 1995a; ). Receptor usage and differential downregulation of CD46 by measles virus wild type and vaccine strains. Proceedings of the National Academy of Sciences, USA 92, 3943-3947.[CrossRef]
    [Google Scholar]
  42. Schneider-Schaulies, J., Dunster, L. M., Kobune, F., Rima, B. & ter Meulen, V. ( 1995b; ). Differential downregulation of CD46 by measles virus strains. Journal of Virology 69, 7257-7259.
    [Google Scholar]
  43. Schneider-Schaulies, J., Schnorr, J.-J., Schglender, J., Dunster, L. M., Schneider-Schaulies, S. & ter Meulen, V. ( 1996; ). Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. Journal of Virology 70, 255-263.
    [Google Scholar]
  44. Schnorr, J.-J., Dunster, L. M., Nanan, R., Schneider-Schaulies, J., Schneider-Schaulies, S. & ter Meulen, V. ( 1995; ). Measles virus induced downregulation of CD46 is associated with enhanced sensitivity to complement mediated lysis of infected cells. European Journal of Immunology 25, 976-984.[CrossRef]
    [Google Scholar]
  45. Seya, T., Nomura, M., Murakami, Y., Begum, N. A., Matsumoto, M. & Nagasawa, S. ( 1998; ). CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (Review). International Journal of Molecular Medicine 1, 809-816.
    [Google Scholar]
  46. Tanaka, K., Xie, M. & Yanagi, Y. ( 1998; ). The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Archives of Virology 143, 213-225.[CrossRef]
    [Google Scholar]
  47. Thorley, B., Milland, J., Christiansen, D., Lanteri, M. B., McInnes, B., Moeller, I., Rivailler, P., Horvat, B., Rabourdin-Combe, C., Gerlier, D., McKenzie, I. F. C. & Loveland, B. ( 1997; ). Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. European Journal of Immunology 27, 726-734.[CrossRef]
    [Google Scholar]
  48. Toyomura, K., Fujimura, T., Murakami, H., Natsume, T., Shigehisa, T., Inoue, N., Takeda, J. & Kinoshita, T. ( 1997; ). Molecular cloning of a pig homologue of membrane cofactor protein (CD46). International Immunology 9, 869-876.[CrossRef]
    [Google Scholar]
  49. Van den Berg, C. W., Perez de la Lastra, J. M., Llanes, D. & Morgan, B. P. ( 1997; ). Purification and characterization of the pig analogue of human cofactor protein/CD46/MCP). Journal of Immunology 158, 1703-1709.
    [Google Scholar]
  50. Wall, R. J., Pursel, V. G., Hammer, R. E. & Brinster, R. L. ( 1985; ). Development of porcine ova that were centrifuged to permit visualization of pronuclei and nuclei. Biology of Reproduction 32, 645.[CrossRef]
    [Google Scholar]
  51. Ward, T., Pipkin, P. A., Clarkson, N. A., Stone, D. M., Minor, P. D. & Almond, J. W. ( 1994; ). Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO Journal 13, 5070-5074.
    [Google Scholar]
  52. White, D. J., Cozzi, E., Langford, G., Oglesby, T., Wang, M. W., Wright, L. & Wallwork, J. ( 1995; ). The control of hyperacute rejection by engineering of the donor species. Eye 9, 185-189.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-6-1431
Loading
/content/journal/jgv/10.1099/0022-1317-81-6-1431
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error